background
synthet
virolog
import
multidisciplinari
scientif
field
emerg
applic
biotechnolog
medicin
aim
develop
method
gener
engin
synthet
virus
particular
mani
rna
virus
includ
among
other
dengu
zika
widespread
pathogen
signific
import
human
health
abil
design
synthes
virus
may
contribut
explor
novel
approach
develop
vaccin
viru
base
therapi
result
develop
full
multidisciplinari
pipelin
gener
analysi
synthet
rna
virus
specif
appli
dengu
viru
serotyp
major
step
pipelin
includ
compar
genom
endogen
synthet
viral
strain
specif
show
although
synthet
virus
found
lower
nucleotid
variabl
phenotyp
reflect
studi
mous
model
morbid
rna
level
neutral
antibodi
similar
even
pathogen
comparison
wildtyp
master
strain
addit
highli
variabl
posit
identifi
analyz
popul
found
overlap
less
conserv
homolog
posit
zika
viru
dengu
serotyp
result
may
suggest
synthet
could
enhanc
virul
correct
sequenc
select
conclus
approach
report
studi
use
gener
analyz
synthet
rna
virus
genotyp
phenotyp
level
could
appli
understand
function
fit
effect
set
mutat
viral
rna
edit
rna
virus
variou
target
applic
abil
synthes
engin
rna
virus
import
applic
biotechnolog
human
health
although
previous
publish
studi
involv
gener
analysi
variou
synthet
rna
virus
eg
ref
studi
requir
understand
evolut
popul
dynam
togeth
develop
effici
synthet
biolog
approach
research
dengu
viru
denv
import
mosquitoborn
rna
flaviviru
four
known
genom
divers
serotyp
genom
posit
polar
singl
strand
rna
approxim
kb
compos
three
part
uniqu
code
sequenc
cd
produc
matur
viral
protein
via
singl
precursor
polyprotein
two
flank
untransl
region
utr
contain
import
structur
function
element
sinc
dengu
import
human
pathogen
wide
recogn
major
public
health
concern
new
insight
biolog
evolutionari
properti
includ
wildtyp
synthet
gener
strain
may
signific
influenc
develop
new
antivir
vaccin
therapi
zika
viru
zikv
also
flaviviru
genu
close
relat
denv
recent
classifi
public
health
emerg
intern
concern
due
recent
outbreak
denv
zikv
genom
encod
three
structur
protein
capsid
precursor
membran
envelop
seven
nonstructur
protein
work
demonstr
first
time
comprehens
analysi
dengu
viru
serotyp
synthet
variant
use
multidisciplinari
pipelin
combin
compar
genom
synthet
biolog
next
gener
sequenc
experi
anim
model
viral
infect
specif
base
new
guinea
c
wildtyp
strain
wt
see
method
two
synthet
variant
gener
compar
genom
denv
serotyp
zikv
well
replic
pathogenesi
analys
mous
model
perform
see
illustr
fig
suggest
approach
also
directli
appli
rna
virus
full
compar
genom
pipelin
synthet
biolog
rna
virus
demonstr
studi
describ
fig
see
method
detail
new
guinea
c
wild
type
viral
strain
fig
sequenc
sanger
fig
ii
see
also
addit
file
section
result
sequenc
use
master
sequenc
gener
synthet
variant
order
demonstr
robust
report
result
two
differ
approach
examin
incellulo
construct
subgenom
infecti
amplicon
fig
iii
pcr
assembl
fulllength
infecti
dna
fig
iv
three
passag
wildtyp
synthet
virus
vero
cell
fig
v
viral
rna
extract
next
gener
sequenc
perform
ng
fig
vi
result
sequenc
verifi
analysi
genom
variant
perform
respect
singl
nucleotid
variat
snv
insert
variant
call
fig
vii
result
compar
popul
sampl
avail
zikv
genom
see
detail
method
fig
viiiiv
respect
sever
genom
featur
nucleotid
variabl
secondari
structur
codon
codon
pair
bia
cpg
gc
content
addit
wildtyp
synthet
virus
gener
assembl
method
compar
vivo
mous
model
fig
x
comparison
includ
weight
chang
surviv
rate
rna
level
neutral
antibodi
ab
follow
subsect
describ
result
analys
ng
compar
genom
analysi
popul
synthet
wt
virus
cell
line
summar
fig
detail
found
method
posit
discov
variant
snv
insert
read
coverag
along
genom
wt
viru
synthet
construct
assembl
incellulo
shown
fig
genom
coordin
annot
specifi
genom
panel
total
variant
found
cd
utr
posit
variant
mark
vertic
bar
blue
red
variant
panel
variant
cd
due
snv
rest
due
insert
snv
cd
synonym
utr
variant
due
insert
insert
due
addit
nucleotid
within
stretch
snv
found
wt
viru
synthet
variant
posit
variant
snv
one
insert
variant
allel
frequenc
vaf
least
also
pass
variou
filter
posit
bia
pb
strand
bia
sb
filter
see
method
mark
red
bar
variant
panel
found
wt
strain
addit
analysi
cd
snv
summar
fig
snv
c
g
expect
major
variat
found
synonym
snv
posit
substitut
vaf
other
vaf
may
indic
polymorph
within
popul
panel
snv
vaf
polymorph
may
relat
either
error
viral
replic
sequenc
error
low
vaf
may
play
role
improv
fit
wt
viru
seven
signific
snv
vaf
also
pass
pb
sb
filter
mark
red
asterisk
posit
cd
snv
compar
popul
sampl
consist
avail
genom
see
method
addit
detail
particular
relat
region
significantli
strong
weak
rna
structur
method
positionwis
nucleotid
variabl
variabl
panel
analyz
specif
snv
cd
found
overlap
region
undergo
conserv
select
strong
weak
mrna
fold
although
overlap
statist
signific
respect
random
pvalu
see
method
result
suggest
snv
relat
secondari
structur
may
influenc
viral
fit
via
effect
rna
fold
moreov
accord
snv
nucleotid
variabl
correspond
posit
align
popul
sampl
quantifi
normal
entropi
see
method
found
ie
snv
tend
appear
less
conserv
posit
also
spearman
correl
variant
frequenc
deriv
ng
data
frequenc
variant
observ
popul
sampl
snv
posit
found
lowinsignific
rho
pvalu
result
may
demonstr
variabl
popul
level
dynam
trait
may
differ
differ
stage
replic
cycl
within
host
across
differ
host
check
relat
variabl
within
sequenc
wt
popul
within
popul
sampl
denv
serotyp
zikv
map
snv
posit
identifi
cd
multipl
align
combin
genom
denv
serotyp
zikv
genom
respect
see
detail
method
analyz
surround
seen
fig
detail
present
sequenc
logo
snv
denv
serotyp
zikv
seen
fig
follow
compar
nucleotid
variabl
posit
variabl
nonsnv
posit
along
cd
specif
sinc
variabl
nucleotid
codon
higher
posit
perform
analysi
nonsnv
posit
distribut
snv
see
detail
method
seen
fig
averag
snv
nucleotid
variabl
higher
averag
variabl
non
snv
posit
denv
serotyp
zikv
empir
pvalu
equal
size
rel
sampl
see
detail
method
result
suggest
snv
posit
also
tend
variabl
denv
serotyp
andor
zikv
final
analyz
associ
snv
addit
local
differ
genom
featur
name
codon
usag
bia
measur
enc
effici
number
fig
result
ng
studi
posit
variant
snv
insert
read
coverag
along
genom
wildtyp
viru
wt
synthet
construct
assembl
incellulo
genom
coordin
annot
specifi
genom
panel
posit
variant
mark
vertic
bar
blue
red
variant
panel
summari
variant
sampl
first
row
variant
panel
samplespecif
variant
three
differ
row
incellulo
assembl
wt
shown
eight
posit
indel
snv
vaf
least
also
pass
posit
bia
strand
bia
filter
mark
red
bar
found
wt
strain
b
analysi
cd
snv
nucleotid
variabl
snv
posit
base
set
align
genom
repres
correspond
sequenc
logo
variabl
panel
coordin
snv
specifi
xaxi
correspond
gene
specifi
bottom
row
variabl
posit
repres
stack
letter
rel
size
letter
indic
frequenc
align
specif
posit
total
height
letter
depict
inform
content
posit
bit
snv
posit
depict
snv
panel
follow
format
refer
codon
refer
aa
variant
codon
variant
aa
alter
nucleotid
mark
red
variant
allel
frequenc
vaf
posit
specifi
vaf
panel
nonsynonym
snv
mark
n
posit
overlap
region
undergo
conserv
select
strong
weak
mrna
fold
base
mark
w
respect
seven
cd
snv
vaf
least
also
pass
posit
bia
strand
bia
filter
mark
red
asterisk
codon
codon
pair
bia
cpb
cpg
content
cpg
gc
content
gc
see
method
variou
studi
relat
featur
differ
genom
mechan
take
part
viral
replic
cycl
relat
viral
fit
exampl
suggest
viral
codon
may
select
improv
translat
effici
among
other
via
adapt
host
trna
pool
translat
resourc
eg
also
suggest
translat
effici
affect
singl
codon
also
distribut
codon
pair
although
debat
whether
featur
direct
select
consequ
distribut
dinucleotid
ref
shown
cpg
pair
underrepres
mani
rna
small
human
dna
virus
correspond
dinucleotid
frequenc
host
phenomenon
relat
exampl
contribut
cpg
stack
basepair
rna
fold
andor
enhanc
innat
immun
respons
virus
elev
cpg
stabil
rna
secondari
structur
also
affect
genom
gc
content
analyz
local
genom
region
codon
found
region
surround
posit
snv
character
significantli
lower
cpg
content
wilcoxon
ranksum
test
pvalu
compar
region
size
nt
contain
snv
fig
explain
higher
mutat
rate
cpg
suppress
region
may
associ
stronger
evolutionari
pressur
possibl
relat
rna
fold
interact
immun
system
howev
find
signific
differ
snv
nonsnv
region
respect
rest
analyz
featur
see
addit
file
section
mous
model
use
character
pathogen
immun
capabl
synthet
gener
assembl
method
infect
wt
viru
result
around
mortal
fig
tabl
consist
intraperiton
infect
mice
previou
studi
lab
synthet
wildtyp
viru
inject
result
mortal
similar
mortal
curv
mice
infect
wt
viru
mortal
rate
caus
synthet
wt
infect
significantli
higher
pvalu
shaminfect
control
fig
weight
loss
observ
variou
time
cours
infect
individu
anim
infect
wt
synthet
although
gener
trend
littl
averag
weight
chang
beyond
baselin
within
group
fig
reason
vehicl
inocul
control
anim
week
old
gain
weight
expect
fig
although
reason
unknown
viral
rna
detect
anim
infect
synthet
serum
collect
day
post
infect
dpi
significantli
pvalu
higher
shaminfect
control
fig
half
anim
inocul
wt
viru
detect
titer
half
rna
level
assay
result
mous
model
studi
percentag
surviv
mice
infect
wildtyp
synthet
pvalu
dpi
furhter
compar
sham
control
b
mean
weight
chang
mice
infect
differ
variant
c
viru
titer
serum
collect
dpi
infect
mice
pvalu
pvalu
compar
sham
control
plaqu
reduct
neutral
titer
serum
taken
dpi
pvalu
compar
sham
control
note
suffici
quantiti
serum
sampl
group
infect
wt
variant
group
infect
synthet
variant
control
group
quantif
neutral
ab
detect
fig
despit
lower
rate
detect
viral
rna
sampl
mean
viral
rna
level
group
significantli
pvalu
elev
compar
control
viral
rna
detect
serum
shaminfect
mice
anticip
anim
infect
synthet
elicit
significantli
pvalu
elev
neutral
ab
level
dpi
compar
shaminfect
control
fig
infect
wt
viru
result
variabl
respons
usual
includ
detect
viral
rna
mortal
neutral
ab
observ
shaminfect
mice
studi
demonstr
construct
multidisciplinari
pipelin
compar
analyz
synthet
wildtyp
virus
central
aspectsstep
pipelin
includ
compar
genom
first
synthet
virus
design
base
compar
genom
analysi
wt
viral
genom
eg
ref
second
synthet
variant
analyz
base
compar
genom
tool
includ
comparison
variant
wt
genom
among
other
studi
demonstr
interact
compar
genom
research
tool
synthet
virolog
specif
report
first
time
set
snv
appear
master
wildtyp
viru
comparison
synthet
construct
gener
wildtyp
viru
found
higher
genom
variabl
ie
nucleotid
variat
synthet
strain
known
popul
viral
variant
import
fit
thu
analysi
demonstr
approach
connect
viral
fit
structur
popul
addit
studi
demonstr
synthet
variant
may
caus
morbid
mortal
wildtyp
viru
also
infect
synthet
viru
result
higher
serum
viral
rna
titer
measur
dpi
consist
high
level
neutral
ab
measur
dpi
compar
infect
wildtyp
find
may
relat
alreadi
mention
fact
synthet
viru
includ
lower
level
genom
sequenc
variabl
rna
virus
often
defin
quasispeci
collect
close
relat
mutant
spectra
mutant
cloud
fact
viru
exist
cloud
close
relat
genom
constitut
evolutionari
advantag
among
other
enabl
viru
effici
adjust
differ
host
cell
therefor
higher
level
variabl
wildtyp
viru
may
improv
replic
rate
host
vero
cell
origin
investig
wildtyp
viru
andor
humansa
aegypti
hand
decreas
fit
replic
rate
mice
also
possibl
wildtyp
viru
undergo
direct
select
reduc
virul
among
other
may
relat
variabl
actual
increas
transmiss
fit
use
assembl
incellulo
synthet
construct
ng
analysi
variant
call
howev
current
due
variou
constraint
mous
model
studi
use
synthet
gener
assembl
method
would
interest
futur
character
properti
incellulo
construct
sinc
incellulo
assembl
virus
differ
snv
might
impact
lethal
approach
describ
perform
rna
viru
use
platform
technolog
ration
design
synthesi
live
attenu
vaccin
rna
virus
specif
near
futur
plan
use
approach
studi
effect
synonym
mutat
fit
variou
type
virus
eg
serotyp
dengu
zika
viru
end
gener
larg
librari
viral
genom
differ
type
synonym
mutat
rna
protein
level
librari
measur
cell
line
model
organ
mutat
connect
observ
studi
present
multidisciplinari
pipelin
combin
tool
synthet
biolog
next
gener
sequenc
compar
genom
engin
synthes
analyz
synthet
rna
virus
appli
pipelin
gener
synthet
dengu
virus
compar
wildtyp
master
strain
particular
show
although
synthet
dengu
virus
found
lower
nucleotid
variabl
phenotyp
reflect
studi
mous
model
morbid
rna
level
neutral
antibodi
similar
even
pathogen
comparison
wildtyp
describ
approach
perform
rna
viru
use
platform
technolog
ration
design
synthesi
oncolyt
rna
virus
live
attenu
vaccin
minimum
essenti
medium
eagl
earl
emem
medium
fetal
bovin
serum
fb
penicillinstreptomycinnystatin
solut
dulbecco
phosphat
buffer
salin
dpb
obtain
biolog
industri
bethaemek
il
optimem
medium
obtain
gibcothermofish
grand
island
ny
miru
reagent
also
use
madison
wi
vero
atcc
cell
cultur
emem
supplement
fetal
calf
serum
streptomycin
mgml
penicillin
uml
nystatin
uml
mgml
co
incub
new
guineac
strain
prepar
vero
cell
grown
emem
medium
contain
inact
fb
streppenni
solut
incub
day
appear
cytopath
effect
cpe
supernat
harvest
divid
aliquot
store
viral
rna
quantifi
use
rtpcr
infecti
tissu
cultur
assay
dengu
viru
type
new
guinea
c
cultur
collect
rna
extract
aliquot
cultur
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
cdna
synthes
use
maxima
h
minu
first
strand
dna
synthesi
kit
thermo
scientif
random
hexam
primer
accord
manufactur
instruct
cdna
amplifi
pcr
bp
overlap
amplicon
use
pfuultra
ii
hotstart
pcr
master
mix
agil
technolog
bp
amplicon
sequenc
use
sanger
method
bp
amplicon
clone
vector
use
clonejet
pcr
clone
kit
thermo
scientif
cytomegaloviru
promot
insert
first
fragment
kb
last
fragment
kb
synthes
use
solidphas
dna
synthesi
method
biobas
follow
hepat
delta
simian
polyadenyl
signal
dengu
subgenom
amplicon
gener
previous
describ
entir
viral
genom
amplifi
pcr
dna
fragment
approxim
kb
bp
overlap
arm
first
fragment
flank
cytomegaloviru
promot
last
fragment
flank
hepat
delta
ribozym
follow
simian
polyadenyl
signal
pcr
product
purifi
use
minelut
pcr
purif
kit
qiagen
ng
equimolar
mix
transfect
vero
cell
line
atcc
dengu
virus
genom
amplifi
pcr
dna
fragment
approxim
kb
bp
overlap
end
first
fragment
flank
cytomegaloviru
promot
last
fragment
flank
hepat
delta
ribozym
follow
simian
polyadenyl
signal
overlap
fragment
extend
use
highfidel
dna
polymeras
new
england
biolab
use
neighbor
fragment
primer
dengu
viru
type
new
guinea
c
cultur
collect
rna
extract
aliquot
cultur
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
cdna
synthes
use
maxima
h
minu
first
strand
dna
synthesi
kit
thermo
scientif
random
hexam
primer
accord
manufactur
instruct
cdna
amplifi
seven
bp
overlap
amplicon
use
pfuultra
ii
hotstart
pcr
master
mix
agil
technolog
pcr
product
separ
agaros
tae
gel
confirm
band
interest
present
without
nonspecif
product
pcr
product
purifi
use
minielut
pcr
purif
kit
qiagen
sequenc
librari
prepar
use
inhous
incpm
dnaseq
protocol
sequenc
illumina
miseq
nano
three
denv
cdna
sampl
sequenc
analyz
one
sampl
wildtyp
wt
strain
wt
sanger
sequenc
use
refer
genom
ng
analysi
two
assembl
incellulo
synthet
variant
viru
synthes
use
two
differ
method
full
length
assembl
pcr
subgenom
infecti
amplicon
wt
sequenc
found
addit
file
section
sequenc
librari
prepar
use
incpm
dnaseq
protocol
sequenc
illumina
miseq
nano
sequenc
read
map
refer
genom
genom
wildtyp
viru
use
bwa
mem
among
readpair
align
singl
repres
read
chosen
use
picard
markdupl
http
broadinstitut
githubiopicard
variant
call
use
freebay
set
f
ploidi
order
increas
sensit
low
allel
fraction
variant
freebay
haplotyp
base
bayesian
genet
variant
detector
design
find
small
polymorph
complex
event
composit
insert
substitut
event
smaller
length
shortread
sequenc
align
use
shortread
align
bam
file
encod
qualiti
score
individu
popul
refer
genom
determin
mostlik
combin
genotyp
popul
posit
refer
posit
put
polymorph
variant
identifi
character
variant
allel
frequenc
vaf
fraction
variant
allel
observ
read
two
type
bias
test
variant
strand
bia
sb
type
sequenc
bia
one
positiveneg
strand
favor
result
incorrect
evalu
amount
evid
observ
one
allel
vs
use
gatk
strandoddsratio
sor
test
determin
strand
bia
forward
revers
strand
refer
altern
allel
posit
sor
valu
may
consid
bias
posit
bia
pb
composit
measur
compos
phred
scale
probabl
observ
posit
bia
within
support
read
variant
posit
pb
valu
may
consid
bias
variant
vaf
pass
sb
pb
filter
mark
especi
signific
strong
popul
sampl
variant
genom
taken
ncbi
genbank
coordin
differ
genom
featur
orfsutr
obtain
refer
strain
align
genom
use
studi
multipl
align
code
region
ie
denv
popul
sampl
region
conserv
select
strong
weak
mrna
fold
comput
addit
perform
multipl
align
dengu
serotyp
combin
zika
popul
sampl
respect
briefli
translat
amino
acid
sequenc
correspond
code
region
align
use
clustal
omega
packag
version
default
paramet
map
back
nucleotid
sequenc
base
origin
nucleotid
composit
code
region
multipl
align
conserv
score
defin
averag
sumofpair
score
sp
see
addit
file
section
access
number
analyz
genom
found
addit
file
local
minimum
free
fold
energi
mfe
profil
construct
appli
nt
length
slide
window
genom
sequenc
step
mfe
local
subsequ
enclos
correspond
window
calcul
vienna
version
packag
rnafold
function
default
paramet
profil
compar
fold
profil
correspond
random
variant
preserv
differ
genom
featur
wildtyp
sequenc
necessarili
directli
relat
mrna
fold
amino
acid
order
content
vertic
distribut
synonym
codon
posit
align
frequenc
dinucleotid
result
region
posit
undergo
significantli
conserv
across
differ
genom
select
synonymoussil
level
weakstrong
mrna
fold
mfeselect
region
identifi
detail
includ
coordin
identifi
region
signific
fold
signal
found
ref
addit
file
section
statist
analysi
overlap
posit
snv
region
select
strongweak
rna
structur
perform
follow
analysi
specif
genom
posit
nucleotid
variabl
respect
popul
sampl
quantifi
normal
shannon
entropi
distribut
nucleotid
normal
maxim
entropi
valu
posit
correspond
align
n
ie
number
differ
possibl
nucleotid
variabl
measur
take
valu
describ
dispers
distribut
alphabet
element
higher
valu
correspond
uniform
nucleotid
usag
lower
valu
correspond
bias
nucleotid
indic
nucleotid
preferredposit
conserv
level
signific
ie
pvalu
commonli
determin
base
wilcoxon
rank
sum
test
empir
pvalu
report
fig
determin
base
comparison
averag
snv
variabl
averag
variabl
set
nonsnv
potion
size
case
sinc
variabl
nucleotid
codon
higher
posit
random
sampl
nonsnv
posit
design
distribut
snv
specif
randomli
select
nonsnv
valu
posit
codon
rel
frequenc
thu
randomli
select
subset
nonsnv
posit
distribut
snv
order
calcul
empir
pvalu
compar
averag
variabl
two
set
ie
snv
nonsnv
nonsnv
set
chosen
random
time
pvalu
determin
follow
let
valu
snv
averag
n
vector
contain
n
random
valu
sampl
nonsnv
valu
th
sampl
p
n
p
n
jf
gj
n
measur
quantifi
far
codon
usag
code
sequenc
depart
equal
usag
synonym
codon
see
detail
addit
file
section
quantifi
codon
pair
bia
follow
defin
codon
pair
score
cp
log
ratio
observ
expect
number
occurr
codon
pair
code
sequenc
see
detail
addit
file
section
follow
comput
dinucleotid
score
dnt
pair
nucleotid
xy
odd
ratio
observ
expect
frequenc
see
detail
addit
file
section
male
femal
week
old
mice
averag
weight
g
use
immunocompromis
natur
strain
mice
produc
hous
hous
presteril
bonnet
hepafilt
cage
ventil
cage
rack
durat
experi
anim
randomli
assign
cage
individu
mark
eartag
instrument
eartag
glove
hand
surfac
came
contact
mice
coldsteril
betadin
solut
andor
etoh
experi
conduct
anim
suit
utah
state
univers
laboratori
anim
research
center
larc
personnel
receiv
continu
special
train
bloodborn
pathogen
handl
univers
environment
health
safeti
offic
standard
oper
procedur
use
viru
titer
plasma
assay
use
brilliant
ii
qrtpcr
master
mix
kit
sampl
run
mic
magnet
induct
cycler
real
time
pcr
machin
bio
molecular
system
inc
briefli
rna
extract
serum
sampl
collect
dpi
use
qiaamp
minelut
viru
spin
kit
qiagen
cat
elut
elut
buffer
volum
rna
prepar
ad
appropri
mixtur
pcr
reagent
follow
manufactur
protocol
viru
stock
known
titer
also
extract
parallel
use
quantif
sampl
subject
cycl
follow
initi
singl
cycl
min
min
sampl
unknown
quantiti
quantifi
extrapol
c
valu
use
curv
gener
serial
dilut
standard
sampl
anim
blockrandom
cage
two
group
includ
group
mice
challeng
intraperiton
ip
wildtyp
synthet
viral
variant
third
group
mice
also
includ
normal
control
shaminfect
vehicl
monitor
handl
inocul
cage
techniqu
effect
immunocompromis
mice
mice
ip
infect
ml
viru
prepar
mortal
observ
daili
day
mice
weigh
day
everi
day
dpi
serum
collect
anim
dpi
quantif
viremia
serum
also
collect
dpi
measur
neutral
antibodi
titer
surviv
data
analyz
use
wilcoxon
logrank
surviv
analysi
statist
analys
perform
use
oneway
anova
bonferroni
group
comparison
anim
human
euthan
met
earli
euthanasia
criteria
accord
institut
approv
protocol
anim
unabl
right
display
sever
neurolog
diseas
human
euthan
anim
observ
least
twice
daili
throughout
studi
death
occur
overnight
occasion
anim
die
without
display
sever
sign
diseas
progress
mortal
span
sever
hour
sinc
analges
anesthet
potenti
interfer
viral
infect
method
util
human
euthanasia
primari
mechan
minim
anim
suffer
distress
anim
research
ethic
committe
utah
state
univers
approv
research
approv
anesthesia
use
studi
asphyxi
co
inhal
use
euthanasia
end
studi
addit
file
supplementari
